Thompson Elizabeth H.Z. 4
4 · ACADIA PHARMACEUTICALS INC · Filed Mar 26, 2025
Insider Transaction Report
Form 4
Thompson Elizabeth H.Z.
EVP, Head of Research & Dev
Transactions
- Award
Stock Option (Right to Buy)
2025-03-24+91,395→ 91,395 totalExercise: $17.23Exp: 2035-03-23→ Common Stock (91,395 underlying) - Award
Restricted Stock Units
2025-03-24+26,861→ 26,861 total→ Common Stock (26,861 underlying)
Footnotes (3)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on March 24, 2026. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning March 24, 2026.